Verve Therapeutics Statistics
Total Valuation
VERV has a market cap or net worth of $1.01 billion. The enterprise value is $580.79 million.
Important Dates
The next estimated earnings date is Thursday, August 7, 2025, before market open.
Earnings Date | Aug 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
VERV has 89.31 million shares outstanding. The number of shares has increased by 23.92% in one year.
Current Share Class | 89.14M |
Shares Outstanding | 89.31M |
Shares Change (YoY) | +23.92% |
Shares Change (QoQ) | +2.21% |
Owned by Insiders (%) | 5.12% |
Owned by Institutions (%) | 72.29% |
Float | 65.49M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 16.07 |
Forward PS | 72.29 |
PB Ratio | 2.09 |
P/TBV Ratio | 2.13 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 9.74 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.84, with a Debt / Equity ratio of 0.14.
Current Ratio | 9.84 |
Quick Ratio | 9.59 |
Debt / Equity | 0.14 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -34.26% and return on invested capital (ROIC) is -21.73%.
Return on Equity (ROE) | -34.26% |
Return on Assets (ROA) | -19.35% |
Return on Invested Capital (ROIC) | -21.73% |
Return on Capital Employed (ROCE) | -37.08% |
Revenue Per Employee | $217,566 |
Profits Per Employee | -$660,606 |
Employee Count | 274 |
Asset Turnover | 0.09 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, VERV has paid $322,000 in taxes.
Income Tax | 322,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +125.10% in the last 52 weeks. The beta is 1.67, so VERV's price volatility has been higher than the market average.
Beta (5Y) | 1.67 |
52-Week Price Change | +125.10% |
50-Day Moving Average | 6.03 |
200-Day Moving Average | 5.92 |
Relative Strength Index (RSI) | 85.36 |
Average Volume (20 Days) | 8,078,349 |
Short Selling Information
The latest short interest is 18.00 million, so 20.15% of the outstanding shares have been sold short.
Short Interest | 18.00M |
Short Previous Month | 19.84M |
Short % of Shares Out | 20.15% |
Short % of Float | 27.48% |
Short Ratio (days to cover) | 5.92 |
Income Statement
In the last 12 months, VERV had revenue of $59.61 million and -$181.01 million in losses. Loss per share was -$2.10.
Revenue | 59.61M |
Gross Profit | -150.82M |
Operating Income | -208.45M |
Pretax Income | -192.38M |
Net Income | -181.01M |
EBITDA | -201.62M |
EBIT | -208.45M |
Loss Per Share | -$2.10 |
Full Income Statement Balance Sheet
The company has $497.08 million in cash and $68.64 million in debt, giving a net cash position of $428.44 million or $4.80 per share.
Cash & Cash Equivalents | 497.08M |
Total Debt | 68.64M |
Net Cash | 428.44M |
Net Cash Per Share | $4.80 |
Equity (Book Value) | 473.51M |
Book Value Per Share | 5.33 |
Working Capital | 459.67M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$142.46 million and capital expenditures -$4.53 million, giving a free cash flow of -$146.98 million.
Operating Cash Flow | -142.46M |
Capital Expenditures | -4.53M |
Free Cash Flow | -146.98M |
FCF Per Share | -$1.65 |
Full Cash Flow Statement Margins
Gross Margin | -252.99% |
Operating Margin | -349.68% |
Pretax Margin | -303.09% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
VERV does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -23.92% |
Shareholder Yield | -23.92% |
Earnings Yield | -17.94% |
FCF Yield | -14.56% |
Analyst Forecast
The average price target for VERV is $14.57, which is 28.94% higher than the current price. The consensus rating is "Buy".
Price Target | $14.57 |
Price Target Difference | 28.94% |
Analyst Consensus | Buy |
Analyst Count | 10 |
Revenue Growth Forecast (5Y) | -4.74% |
EPS Growth Forecast (5Y) | 6.59% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
VERV has an Altman Z-Score of 0.31 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 0.31 |
Piotroski F-Score | 3 |